Correspondence (letter to the editor): Treatment Option not Mentioned

by Ezziddin, Samer, Biersack, Hans-Jürgen
Published 2013

Correspondence (letter to the editor): Radioembolization as a Treatment Option

by Ezziddin, Samer, Bücker, Arno, Lammert, Frank
Published in Dtsch Arztebl Int (2015)

Diagnosis of extra-adrenal phaeochromocytoma after nephrectomy

by Barski, Dimitri, Ezziddin, Samer, Heikaus, Sebastian, Neumann, Hartmut P.H.
Published 2014

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

by Biersack Hans-Jürgen, Wilinek Winfried, Herrlinger Ulrich, Ahmadzadehfar Hojjat, Sabet Amir, Ezziddin Samer
Published 2011-08-01

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

by Sabet, Amir, Ahmadzadehfar, Hojjat, Herrlinger, Ulrich, Wilinek, Winfried, Biersack, Hans-Jürgen, Ezziddin, Samer
Published 2011

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of (131)I-MIBG

by Ezziddin, Samer, Sabet, Amir, Ko, Yon-Dschun, Xun, Sunny, Matthies, Alexander, Biersack, Hans-Jürgen
Published 2012

May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreo...

by Sabet, Amir, Khalaf, Feras, Mahjoob, Soha, Al-Zreiqat, Abdullah, Biersack, Hans-Jürgen, Ezziddin, Samer
Published 2013

Does PRRT with standard activities of (177)Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor...

by Sabet, Amir, Nagarajah, James, Dogan, Ahmet Semih, Biersack, Hans-Jürgen, Sabet, Amin, Guhlke, Stefan, Ezziddin, Samer
Published 2013

Molecular imaging and biochemical response assessment after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [(17...

by Rosar, Florian, Hau, Fabian, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Published in Theranostics (2021)

Renal Safety of [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

by Rosar, Florian, Kochems, Niklas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Khreish, Fadi, Ezziddin, Samer
Published in Cancers (Basel) (2021)

Determination of split renal function by PSMA imaging: comparison of (68)Ga-PSMA-11 PET with (99m)Tc-MAG3 scintigraphy

by Rosar, Florian, Pauly, Peter, Ries, Martin, Schaefer-Schuler, Andrea, Maus, Stephan, Schreckenberger, Mathias, Khreish, Fadi, Ezziddin, Samer
Published in Am J Nucl Med Mol Imaging (2020)

Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients

by Rosar, Florian, Ribbat, Kalle, Ries, Martin, Linxweiler, Johannes, Bartholomä, Mark, Maus, Stephan, Schreckenberger, Mathias, Ezziddin, Samer, Khreish, Fadi
Published in EJNMMI Res (2020)

Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of (64)Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates

by Martin, Sebastian, Maus, Stephan, Stemler, Tobias, Rosar, Florian, Khreish, Fadi, Holland, Jason P., Ezziddin, Samer, Bartholomä, Mark D.
Published in Mol Imaging Biol (2020)

Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

by Rosar, Florian, Krause, Jonas, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Hierlmeier, Ina, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Published in Pharmaceutics (2021)

Efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis

by Sabet, Amir, Haug, Alexander R, Eiden, Collin, Auernhammer, Christoph J, Simon, Birgit, Bartenstein, Peter, Biersack, Hans J, Ezziddin, Samer
Published in Am J Nucl Med Mol Imaging (2017)

Comparison of different methods for post-therapeutic dosimetry in [(177)Lu]Lu-PSMA-617 radioligand therapy

by Rosar, Florian, Schön, Niklas, Bohnenberger, Hendrik, Bartholomä, Mark, Stemler, Tobias, Maus, Stephan, Khreish, Fadi, Ezziddin, Samer, Schaefer-Schuler, Andrea
Published in EJNMMI Phys (2021)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

by Handkiewicz-Junak, Daria, Poeppel, Thorsten D., Bodei, Lisa, Aktolun, Cumali, Ezziddin, Samer, Giammarile, Francesco, Delgado-Bolton, Roberto C., Gabriel, Michael
Published in Eur J Nucl Med Mol Imaging (2018)

Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis

by Sabet, Amir, Khalaf, Feras, Haslerud, Torjan, Al-Zreiqat, Abdullah, Sabet, Amin, Simon, Birgit, Pöppel, Thorsten D, Biersack, Hans-Jürgen, Ezziddin, Samer
Published 2013

The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer

by Fleckenstein, Jochen, Jelden, Michael, Kremp, Stephanie, Jagoda, Philippe, Stroeder, Jonas, Khreish, Fadi, Ezziddin, Samer, Buecker, Arno, Rübe, Christian, Schneider, Guenther K.
Published in PLoS One (2016)

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and s...

by Dizdarevic, Sabina, Petersen, Peter Meidahl, Essler, Markus, Versari, Annibale, Bourre, Jean-Cyril, la Fougère, Christian, Valdagni, Riccardo, Paganelli, Giovanni, Ezziddin, Samer, Kalinovský, Ján, Bayh, Inga, Du, Yong
Published in Eur J Nucl Med Mol Imaging (2019)